期刊文献+

Genotype specific peripheral lipid profile changes with hepatitis C therapy

Genotype specific peripheral lipid profile changes with hepatitis C therapy
下载PDF
导出
摘要 AIM To evaluate magnitude/direction of changes in peripheral lipid profiles in patients undergoing direct acting therapy for hepatitis C by genotype.METHODS Mono-infected patients with hepatitis C were treated with guideline-based DAAs at a university-based liver clinic. Patient characteristics and laboratory values were collected before and after the treatment period. Baseline demographics included age, ethnicity, hypertension, diabetes, hyperlipidemia, treatment regimen, and fibrosis stage. Total cholesterol(TCHOL), high density lipoprotein(HDL), low density lipoprotein(LDL), triglycerides(TG), and liver function tests were measured prior to treatment and ETR. Changes in lipid and liver function were evaluated by subgroups with respect to genotype. Mean differences were calculated for each lipid profile and liver function component(direction/magnitude). The mean differences in lipid profiles were then compared between genotypes for differences in direction/magnitude. Lipid profile and liver function changes were evaluated with Levene's test and student's t test. Mean differences in lipid profiles were compared between genotypes using ANOVA, post hoc analysis via the Bonferroni correction or Dunnett T3.RESULTS Three hundred and seventy five patients enrolled with 321(85.6%) achieving sustained-viral response at 12 wk. 72.3% were genotype 1(GT1), 18.1% genotype 2(GT2), 9.7% genotype 3(GT3). Baseline demographics were similar. Significant change in lipid profiles were seen with GT1 and GT3(ΔGT1, p and ΔGT3, p), with TCHOL increasing(+5.3, P = 0.005 and +16.1, P < 0.001), HDL increasing(+12.5, P < 0.001 and +7.9, P = 0.038), LDL increasing(+7.4, P = 0.058 and +12.5, P < 0.001), and TG decreasing(-5.9, P = 0.044 and-9.80 P = 0.067). Among genotypes(ΔGT1 v. ΔGT2 v. ΔGT3, ANOVA), significant mean differences were seen with TCHOL(+5.3 v. +0.1 v. +16.1, P = 0.017) and HDL(+12.3 v. +2 v. +7.9, P = 0.040). Post-hoc, GT3 was associated with a greater increase in TCHOL than GT1 and GT2(P = 0.028 and P = 0.019).CONCLUSI AIM To evaluate magnitude/direction of changes in peripheral lipid profiles in patients undergoing direct acting therapy for hepatitis C by genotype.METHODS Mono-infected patients with hepatitis C were treated with guideline-based DAAs at a university-based liver clinic. Patient characteristics and laboratory values were collected before and after the treatment period. Baseline demographics included age, ethnicity, hypertension, diabetes, hyperlipidemia, treatment regimen, and fibrosis stage. Total cholesterol(TCHOL), high density lipoprotein(HDL), low density lipoprotein(LDL), triglycerides(TG), and liver function tests were measured prior to treatment and ETR. Changes in lipid and liver function were evaluated by subgroups with respect to genotype. Mean differences were calculated for each lipid profile and liver function component(direction/magnitude). The mean differences in lipid profiles were then compared between genotypes for differences in direction/magnitude. Lipid profile and liver function changes were evaluated with Levene’s test and student’s t test. Mean differences in lipid profiles were compared between genotypes using ANOVA, post hoc analysis via the Bonferroni correction or Dunnett T3.RESULTS Three hundred and seventy five patients enrolled with 321(85.6%) achieving sustained-viral response at 12 wk. 72.3% were genotype 1(GT1), 18.1% genotype 2(GT2), 9.7% genotype 3(GT3). Baseline demographics were similar. Significant change in lipid profiles were seen with GT1 and GT3(ΔGT1, p and ΔGT3, p), with TCHOL increasing(+5.3, P = 0.005 and +16.1, P < 0.001), HDL increasing(+12.5, P < 0.001 and +7.9, P = 0.038), LDL increasing(+7.4, P = 0.058 and +12.5, P < 0.001), and TG decreasing(-5.9, P = 0.044 and-9.80 P = 0.067). Among genotypes(ΔGT1 v. ΔGT2 v. ΔGT3, ANOVA), significant mean differences were seen with TCHOL(+5.3 v. +0.1 v. +16.1, P = 0.017) and HDL(+12.3 v. +2 v. +7.9, P = 0.040). Post-hoc, GT3 was associated with a greater increase in TCHOL than GT1 and GT2(P = 0.028 and P = 0.019).CONC
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第46期10226-10231,共6页 世界胃肠病学杂志(英文版)
关键词 Hepatitis C genotypes LIPIDS Metabolic syndrome 丙肝遗传型;类脂化合物;新陈代谢的症候群
  • 相关文献

参考文献2

二级参考文献23

  • 1Tarek E Korah,Sawsan El-Sayed,Maathir K ElShafie,Ghada E Hammoda,Manal A Safan.Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis[J].World Journal of Hepatology,2013,5(2):74-81. 被引量:7
  • 2Zheng-WenLiu,NiZhang,Qun-YingHan,Jun-TaoZeng,Yong-LieChu,Jian-MingQiu,Ya-WenWang,Lie-TingMa,xiao-Qinwang.Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection[J].World Journal of Gastroenterology,2005,11(22):3357-3362. 被引量:4
  • 3Ming-Ling Chang,Jeng-Chang Chen,Chau-Ting Yeh,I-Shyan Sheen,Dar-In Tai,Ming-Yu Chang,Cheng-Tang Chiu,Deng-Yn Lin,D Montgomery Bissell.Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: Studies in vitro and in conditionally transgenic mice[J].World Journal of Gastroenterology,2007,13(25):3472-3477. 被引量:4
  • 4Eric Trépo,Thierry Gustot,Delphine Degré,Arnaud Lemmers,Laurine Verset,Pieter Demetter,Romy Ouziel,Eric Quertinmont,Vincent Vercruysse,Leila Amininejad,Pierre Deltenre,Olivier Le Moine,Jacques Devière,Denis Franchimont,Christophe Moreno.Common polymorphism in the PNPLA3 /adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease[J].Journal of Hepatology.2011(4) 被引量:2
  • 5D.Lavanchy.Evolving epidemiology of hepatitis?C virus[J]. Clinical Microbiology and Infection . 2011 (2) 被引量:7
  • 6Dongliang Ge,Jacques Fellay,Alexander J. Thompson,Jason S. Simon,Kevin V. Shianna,Thomas J. Urban,Erin L. Heinzen,Ping Qiu,Arthur H. Bertelsen,Andrew J. Muir,Mark Sulkowski,John G. McHutchison,David B. Goldstein.Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature . 2009 被引量:3
  • 7Maria Cubero,Josep Gregori,Juan I. Esteban,Damir García‐Cehic,Marta Bes,Celia Perales,Esteban Domingo,Francisco Rodríguez‐Frías,Silvia Sauleda,Rosario Casillas,Alex Sanchez,Israel Ortega,Rafael Esteban,Jaume Guardia,Josep Quer.Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection[J]. Liver Int . 2014 (6) 被引量:1
  • 8L. Rojas,J. Ampuero,J.A. Del Campo,R.J. Garcia-Lozano,R. Solá,X. Forns,R. Moreno-Otero,R. Andrade,M. Diago,J. Salmeron,L. Rodrigo,J.A. Pons,J.M. Navarro,J.L. Calleja,J. Garcia-Samaniego,M. Buti,J. Crespo,C. Fernandez-Rodriguez,R. Millan,M.F. Gonzalez-Escribano,M. Romero-Gomez.P219 FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV)[J]. Journal of Hepatology . 2014 (1) 被引量:1
  • 9á. Rojas,J. A. del Campo,M. Maraver,R. Aparcero,M. García‐Valdecasas,M. Diago,I. Carmona,R. J. Andrade,R. Solà,M. Romero‐Gómez.Hepatitis C virus infection alters lipid metabolism depending on IL 28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro[J]. J Viral Hepat . 2014 (1) 被引量:1
  • 10Eiichi Ogawa,Norihiro Furusyo,Eiji Kajiwara,Hideyuki Nomura,Kazufumi Dohmen,Kazuhiro Takahashi,Makoto Nakamuta,Takeaki Satoh,Koichi Azuma,Akira Kawano,Yuichi Tanabe,Kazuhiro Kotoh,Shinji Shimoda,Jun Hayashi.Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection[J]. Antiviral Research . 2014 被引量:1

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部